Paying for a full-body MRI can feel like taking charge of your health, especially when the goal is to find problems before symptoms appear. But for adults who feel well and have no particular risk factors, is it a worthwhile screening test?
In this episode, Dr. Tara Moroz explores what direct-to-consumer whole-body MRI scans find, including cancers and non-cancer abnormalities that may require follow-up. She examines why a concerning result isn't necessarily a harmful condition, why a normal scan cannot rule out every disease, and what the research can—and cannot—tell us about further imaging, procedures, costs and psychological effects.
The central question is not simply how much a scan can detect. It's whether more detection leads to better health for average-risk adults compared with established screening based on age and risk.
Listen to the episode — then explore the full transcript and evidence in The Evidence Edit.
